Bevatas 300mg Solution for Infusion


Product Info

Prescription required Yes
Marketer Intas Pharmaceuticals Ltd
Active Ingredient Bevacizumab (300mg)
Storage Store in a refrigerator (2 - 8°C). Do not freeze.
Chemical ClassMonoclonal antibody (mAb)
Habit FormingNo
Therapeutic ClassANTI NEOPLASTICS
Action ClassVascular endothelial growth factor (VEGF) inhibitor
User Rating4.8
User Reviews388

FAQ

Question
What kinds of cancer can Bevatas 300mg Solution for be used for ?
Bevatas 300mg Solution for is approved for the treatment of cancer of the colon or rectum that has spread to other parts of the body. It must be given along with chemotherapy. Other types of cancers that it helps with includes certain types of lung cancer, kidney cancer, ovarian cancer, cervical cancer, and glioblastoma (a type of brain tumor).
Answer

Question
Does a person taking Bevatas 300mg Solution for still need chemotherapy?
Chemotherapy is still needed along with taking Bevatas 300mg Solution for. It makes chemotherapy work better.
Answer

Question
How is Bevatas 300mg Solution for given?
Bevatas 300mg Solution for is given as an infusion. That means you get it through a small needle in your vein or through a port, which is a device placed under your skin. Your doctor will decide your dose and duration and will monitor you for signs of an infusion reaction.
Answer

Question
How long can I take Bevatas 300mg Solution for for?
You keep taking Bevatas 300mg Solution for as long as your disease is controlled and your side effects are manageable. Your doctor will determine whether you should stop taking Bevatas 300mg Solution for. If your cancer progresses during this initial treatment, talk to your doctor if a different chemotherapy may be an option.
Answer

Question
How Bevatas 300mg Solution for works differently from chemotherapy?
Chemotherapy attacks fast-growing cells, like cancer cells. In contrast, the purpose of Bevatas 300mg Solution for is to prevent the growth of new blood vessels that feed tumors. This causes the tumour to shrink, or to stop growing.
Answer
Question
What if you forget to take Bevatas Solution for Infusion?
If you miss a dose of Bevatas 300mg Solution for, please consult your doctor.
Answer

Bevatas 300mg Solution for Infusion Reviews

Bevatas 300mg Solution for is an anticancer medication. It is used in the treatment of cancer of colon and rectum, non-small cell lung cancer, kidney cancer, brain tumor, ovarian and cervical cancer. It helps to prevent the growth of new blood vessels that feed tumors and stops tumors from growing.

Bevatas 300mg Solution for is an effective medicine, first-line option when used together with other cancer medicines. It is given as an infusion. That means you get it through a small needle in your vein or through a port, which is a device placed under your skin. The doctor will decide your dose and duration and will check you for signs of an infusion reaction such as high blood pressure and trouble breathing. You keep taking Bevatas 300mg Solution for as long as your disease is controlled and your side effects are manageable. Your doctor will determine whether you should stop taking it or not. You may be advised to check blood pressure and levels of protein in urine while you are taking this medication.

The most common side effects of this medicine include rectal bleeding, taste change, and headache. Inform your doctor that you are taking this medication before undergoing any surgical procedure, as the drug has ability to lower the ability of wound healing. Other than this, it also enhances your risk of bleeding thus if you notice any unusual bleeding or bleeding consult with your doctor immediately.

Inform your doctor if you are pregnant, planning pregnancy or breastfeeding. Many other medicines can affect, or be affected by, this medicine so let your healthcare team know all medications you are using.

How Bevatas 300mg Solution for Infusion Works

Bevatas 300mg Solution for is a anti-angiogenic medication. It works by blocking a protein called vascular endothelial growth factor (VEGF). This stops the formation of blood vessels that bring oxygen and nutrients to cancerous cells.

How to Use Bevatas 300mg Solution for Infusion

Your doctor or nurse will give you this medicine. Kindly do not self-administer.

Uses of Bevatas 300mg Solution for Infusion

  • Cervical cancer
  • Non-small cell lung cancer
  • Ovarian cancer
  • Cancer of colon and rectum
  • Kidney cancer
  • Brain tumor

Bevatas 300mg Solution for Infusion Side Effects

Item form

Safety Tips

Liver  SAFE IF PRESCRIBED
Bevatas 300mg Solution for is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of Bevatas 300mg Solution for may not be needed in these patients. Please consult your doctor.
Kidney  SAFE IF PRESCRIBED
Bevatas 300mg Solution for is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Bevatas 300mg Solution for may not be needed in these patients. Please consult your doctor.
Alcohol  CONSULT YOUR DOCTOR
It is not known whether it is safe to consume alcohol with Bevatas 300mg Solution for. Please consult your doctor.
Breast feeding  CONSULT YOUR DOCTOR
Bevatas 300mg Solution for is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Pregnancy  CONSULT YOUR DOCTOR
Bevatas 300mg Solution for may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Driving  UNSAFE
Bevatas 300mg Solution for may cause side effects which could affect your ability to drive.Sleepiness and fainting have been reported with Bevatas 300mg Solution for and this may impair your ability to drive.

Quick Tips

  • Your doctor may regularly check your blood pressure and levels of protein in your urine while you are on Bevatas 300mg Solution for.
  • Bevatas 300mg Solution for is given as an infusion. Your doctor or nurse will monitor you for signs of an infusion reaction such as high blood pressure and trouble breathing.
  • Bevatas 300mg Solution for is given as an infusion. Your doctor or nurse will monitor you for signs of an infusion reaction such as high blood pressure and trouble breathing.
  • It can increase the risk of bleeding. Inform your doctor if you notice any unusual bleeding or bleeding that doesn't stop easily.
  • It can lower your wound healing ability. Inform your doctor that you are taking this medication before undergoing any surgical procedure.
  • Bevatas 300mg Solution for is an effective, first-line option when used together with other medicines for certain types of cancers such as colorectal, lung, cervical, and kidney cancers.
  • It can lower your wound healing ability. Inform your doctor that you are taking this medication before undergoing any surgical procedure.
  • Bevatas 300mg Solution for is an effective, first-line option when used together with other medicines for certain types of cancers such as colorectal, lung, cervical, and kidney cancers.
  • Your doctor may regularly check your blood pressure and levels of protein in your urine while you are on Bevatas 300mg Solution for.
  • It can increase the risk of bleeding. Inform your doctor if you notice any unusual bleeding or bleeding that doesn't stop easily.

References

  1. Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006. Bevacizumab. [Updated 2019 Jul 20].
  2. Bevacizumab. South San Francisco, California: Genentech, Inc.; 2004 [revised Sep. 2011].
  3. Chabner BA, Barnes J, Neal J, et al. Targeted Therapies: Tyrosine Kinase Inhibitors, Monoclonal Antibodies, and Cytokines. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. pp. 1739-40.
  4. Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 142-43.
  5. Chu E, Sartorelli AC. Cancer Chemotherapy. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. p. 955.

Other Medical Preparations